We were delighted to catch up with Dr Sara Tomassetti (Careggi University Hospital, Florence, Italy) around interstitial lung changes following SARS-CoV-2 infection.
The abstract ‘A Multidisciplinary Multicenter Study Evaluating Risk Factors, Prevalence and Characteristics of Post-COVID-19 Interstitial Lung Syndrome PCOILS.‘ (ABSTRACT NUMBER: A1748) was presented at ATS 2021 International Conference, 14-19 May, 2021.
Questions
- What is known about interstitial lung changes following SARS-CoV-2 infection? (0:33)
- What were the aims and design of your study? (3:13)
- What high-resolution computed tomography (HRCT) changes were seen in the interim analysis? (4:51)
- Were any common factors identified in patients with interstitial lung changes, and what further studies are warranted? (6:30)
- What are the potential treatment options for patients with interstitial lung changes following SARS-CoV-2 infection? (7:17)
Disclosures: Sara Tomassetti has nothing to disclose in relation to this video
Support:Â Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of ATSÂ 2021 (Virtual).
